|
NZ544618A
|
|
Antibodies specific for sclerostin and methods for increasing bone mineralization
|
|
NZ542587A
|
|
Complex comprising a TGF-beta binding protein and a BMP antagonist protein in specific association used to modulate bone mineralization
|
|
EP2258724A1
|
|
Modulating immune responses using multimerized anti-CD83 antibodies
|
|
US2004009535A1
|
|
Compositions and methods for increasing bone mineralization
|
|
US2003235847A1
|
|
Association of polymorphisms in the SOST gene region with bone mineral density
|
|
WO03073991A2
|
|
Methods to increase or decrease bone density
|
|
US2006083740A1
|
|
Manipulation of cytokine levels using CD83 gene products
|
|
CA2442134A1
|
|
Compositions and methods for diagnosing or treating psoriasis
|
|
WO02062797A2
|
|
Pharmaceutical uses and synthesis of diketopiperazines
|
|
US2003069305A1
|
|
Pharmaceutical uses and synthesis of benzobicyclooctanes
|
|
WO02051851A2
|
|
Pharmaceutical uses and synthesis of benzobicyclooctanes
|
|
CA2604066A1
|
|
Compositions and methods for diagnosing or treating psoriasis
|
|
US2002115148A1
|
|
Compositions and methods for diagnosing or treating psoriasis
|
|
US6475739B2
|
|
Methods for identifying genomic deletions
|
